Skip to content
logo

SABCS® 2026

  • Home
  • News
    • 2026 Meeting News
    • 2026 Presenter Profiles
    • 2026 SABCS Snippets
    • Archives
      • All 2025 News
      • SABCS Snippets 2025
      • Custom Clinical Content
  • Advocacy
  • Patient Advocacy
  • Industry Events
    • Featured Industry Events
    • Satellite Educational Symposia
    • Product Theaters
  • Industry Connections
  • Publications
    • Meeting Magazine
    • SABCS Takeaways
  • Magazine
  • Photos
  • Photo Gallery
    • SABCS.org
    • Register Now
    • Instagram
    • Facebook
    • X
    • bluesky
    • linkedin
  • Get Email Updates
  • December 8–11
    San Antonio, Texas
SABCS.org
Register Now

Get Email Updates

 |  December 8–11  |  San Antonio, Texas

  • Instagram
  • Facebook
  • X
  • YouTube
  • Bluesky
  • LinkedIn
  • Special session to provide holistic view of AI use in breast cancer care
    November 16, 2026

    Special session to provide holistic view of AI use in breast cancer care

    more: Special session to provide holistic view of AI use in breast cancer care
  • Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
    November 16, 2026

    Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer

    Read more: Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
  • Clinical controversies session to examine evolving treatment approaches in early breast cancer
    November 16, 2026

    Clinical controversies session to examine evolving treatment approaches in early breast cancer

    Read more: Clinical controversies session to examine evolving treatment approaches in early breast cancer
  • Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
    November 16, 2026

    Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes

    Read more: Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
  • Special session to highlight emerging vaccines in the prevention and interception of breast cancer
    November 2, 2026

    Special session to highlight emerging vaccines in the prevention and interception of breast cancer

    Read more: Special session to highlight emerging vaccines in the prevention and interception of breast cancer
  • Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
    November 16, 2026

    Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer

    Read more: Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
  • Clinical controversies session to examine evolving treatment approaches in early breast cancer
    November 16, 2026

    Clinical controversies session to examine evolving treatment approaches in early breast cancer

    Read more: Clinical controversies session to examine evolving treatment approaches in early breast cancer
  • Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
    November 16, 2026

    Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes

    Read more: Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
  • Special session to highlight emerging vaccines in the prevention and interception of breast cancer
    November 2, 2026

    Special session to highlight emerging vaccines in the prevention and interception of breast cancer

    Read more: Special session to highlight emerging vaccines in the prevention and interception of breast cancer

More news from SABCS 2026


  • Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer
    November 16, 2026

    Translational controversies session to explore MRD and ctDNA potential in early and metastatic breast cancer

    David Cescon, MD, PhD, will moderate a session on the use of circulating tumor DNA (ctDNA) tests to detect molecular or minimal residual disease (MRD).

  • Clinical controversies session to examine evolving treatment approaches in early breast cancer
    November 16, 2026

    Clinical controversies session to examine evolving treatment approaches in early breast cancer

    Kelly Hunt, MD, will moderate a panel discussion addressing emerging treatment strategies for smaller, hormone receptor-positive breast cancers.

  • Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes
    November 16, 2026

    Session to review impact of modern weight-loss therapies on breast cancer risk and outcomes

    Jennifer A. Ligibel, MD, will moderate a special session that will outline preliminary findings and unanswered questions about the potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in breast cancer prevention and control.

  • November 2, 2026

    Special session to highlight emerging vaccines in the prevention and interception of breast cancer

    Read more: Special session to highlight emerging vaccines in the prevention and interception of breast cancer
  • November 2, 2026

    Presenters to examine landscape of breast cancer worldwide

    Read more: Presenters to examine landscape of breast cancer worldwide
  • November 2, 2026

    Experts to shine spotlight on unique challenges of lobular breast cancer

    Read more: Experts to shine spotlight on unique challenges of lobular breast cancer
Read More

Patient Advocacy Spotlight


  • Patient advocacy at SABCS: Partnering for progress in breast cancer research

    Patient advocacy at SABCS: Partnering for progress in breast cancer research

    One of the San Antonio Breast Cancer Symposium’s most unique elements is its commitment to giving a platform to patients living with the disease, as well as knowledgeable advocates, throughout its programming.

  • Visit the SABCS Patient Advocacy Pavilion

    Visit the SABCS Patient Advocacy Pavilion

    The Patient Advocacy Pavilion is a dedicated space in the SABCS Exhibit Hall that fosters connection, collaboration, and education around patient-centered breast cancer care.

  • Panel to discuss integrating lifestyle medicine into breast cancer care

    Panel to discuss integrating lifestyle medicine into breast cancer care

    Tara Sanft, MD, will moderate a special session detailing the science behind lifestyle medicine and its impact on the long-term care of patients with breast cancer.

Read More

View Archives


2025
2024
2023
2022
2021
2020

San Antonio Breast Cancer Symposium®

7979 Wurzbach Road, MC 8224, San Antonio, Texas 78229 USA | Telephone: 210-450-1550 | sabcs.org

San Antonio Breast Cancer Symposium, SABCS, and the SABCS logo are trademarks of UT Health San Antonio.

The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas at San Antonio designates this live activity up to a maximum of 81.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation.

© 2026 SABCS. All Rights Reserved. • Powered By TriStar Event Media, LLC.

Privacy Policy

Get updates from SABCS Meeting News

Subscribe below to get email updates from SABCSMeetingNews.org